Timing of Chemotherapy After Breast Cancer Surgery
Author Information
Author(s): Cold S, Düring M, Ewertz M, Knoop A, Møller S
Primary Institution: Danish Breast Cancer Cooperative Group
Hypothesis
Does timing of adjuvant chemotherapy influence the prognosis after early breast cancer?
Conclusion
Delaying the start of adjuvant chemotherapy for early breast cancer does not improve survival outcomes.
Supporting Evidence
- 98% of patients started chemotherapy within 3 months of surgery.
- No significant survival benefit was observed for early initiation of chemotherapy.
- Patients with poor prognostic factors did not show improved outcomes with early chemotherapy.
Takeaway
This study found that it doesn't matter if breast cancer patients start chemotherapy right after surgery or wait a little while; their chances of survival are about the same.
Methodology
The study analyzed data from 7501 breast cancer patients who received chemotherapy within 3 months of surgery, categorizing them based on the timing of chemotherapy initiation.
Potential Biases
Physicians may have influenced the timing of chemotherapy based on patients' prognoses.
Limitations
The study is not randomized, which may introduce bias in treatment allocation.
Participant Demographics
The study included 7501 Danish breast cancer patients treated between 1977 and 1999.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website